raloxifene hydrochloride has been researched along with Dyslipidemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaman, MA; Li, N; Wang, N; Yang, F | 1 |
| Mori, S | 1 |
2 review(s) available for raloxifene hydrochloride and Dyslipidemia
| Article | Year |
|---|---|
Raloxifene has favorable effects on the lipid profile in women explaining its beneficial effect on cardiovascular risk: A meta-analysis of randomized controlled trials.
Topics: Cardiovascular Diseases; Dyslipidemias; Estrogen Antagonists; Heart Disease Risk Factors; Humans; Lipid Metabolism; Lipids; Protective Factors; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic | 2021 |
[Pharmacotherapy of osteoporosis accompanied by lifestyle-related diseases].
Topics: Adrenergic beta-Antagonists; Animals; Cardiovascular Diseases; Diabetes Complications; Diphosphonates; Dyslipidemias; Fractures, Bone; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypoglycemic Agents; Life Style; Osteogenesis; Osteoporosis; Raloxifene Hydrochloride; Thiazolidinediones; Vitamin D | 2011 |